Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rapid-Onset Opioids for Exertional Dyspnea in Cancer Patients
NCT04188418Phase 3Active, not recruiting
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Oct 2020
- Primary completion
- Aug 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of fentanyl sublingual tablet, morphine, sponsored by University of Texas MD Anderson Cancer Center. Started Oct 2020; status: active, not recruiting.
02
Drugs
fentanyl sublingual tabletmorphine
Beyond the preview
Go deeper on NCT04188418.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04188418.